Jacobs Levy Equity Management, Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $25.8 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 16, 2023
SELL
$1.61 - $2.54 $5.58 Million - $8.8 Million
-3,463,754 Reduced 93.11%
256,300 $463,000
Q2 2023

Aug 14, 2023
SELL
$1.14 - $1.95 $3.47 Million - $5.93 Million
-3,042,954 Reduced 44.99%
3,720,054 $6.92 Million
Q1 2023

May 15, 2023
BUY
$1.2 - $2.19 $8.12 Million - $14.8 Million
6,763,008 New
6,763,008 $8.99 Million

Others Institutions Holding DNA

# of Institutions
29
Shares Held
48M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $19B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email